Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithrombotic Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07430917
What this trial is testing

Safety and Efficacy of J147 in Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Abrexa Pharmaceuticals, Inc. 196
Not applicableStudy completedNCT06667882
What this trial is testing

Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests

Who this might be right for
Pulmonary Embolism Subacute MassiveComplication of TreatmentFibrinolysis; Hemorrhage
Semmelweis University 33
Not applicableLooking for participantsNCT07712445
What this trial is testing

Study on the Thrombolytic Effect of Platelet Membrane Coated Tenecteplase on Human Arterial Thrombus

Who this might be right for
Arterial Thrombosis
The First Affiliated Hospital with Nanjing Medical University 24
Not applicableActive Not RecruitingNCT04066556
What this trial is testing

SMART-EST(Specialized Multi-center Attributed Registry of sTroke - EndovaScular or Thrombolytic Therapy)

Who this might be right for
Ischemic Stroke
Yonsei University 5,000
Large-scale testing (Phase 3)Study completedNCT00790920
What this trial is testing

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke

Who this might be right for
Stroke
H. Lundbeck A/S 492
Testing effectiveness (Phase 2)Ended earlyNCT03806556
What this trial is testing

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

Who this might be right for
Pediatric CancerThrombocytopeniaHemostatic Disorder+1 more
Meghan McCormick 11
Large-scale testing (Phase 3)WithdrawnNCT02604238
What this trial is testing

Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Azienda U.S.L. 1 di Massa e Carrara
Testing effectiveness (Phase 2)Study completedNCT05172934
What this trial is testing

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

Who this might be right for
Ischemic Stroke
ProMedica Health System 20
Post-approval studies (Phase 4)Study completedNCT00781378
What this trial is testing

Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China

Who this might be right for
Pulmonary EmbolismThromboembolism
Beijing Chao Yang Hospital 118
Testing effectiveness (Phase 2)Study completedNCT01472926
What this trial is testing

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)

Who this might be right for
Stroke
NHS Greater Glasgow and Clyde 104
Not applicableUnknownNCT02706080
What this trial is testing

Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

Who this might be right for
Antithrombotic Agents
University Hospital, Clermont-Ferrand 10
Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Not applicableStudy completedNCT00283868
What this trial is testing

Stroke Team Remote Evaluation Using a Digital Observation Camera

Who this might be right for
Stroke
University of California, San Diego 234
Large-scale testing (Phase 3)UnknownNCT01134237
What this trial is testing

Intrapleural Urokinase for Retained Hemothorax

Who this might be right for
Retained Hemothorax
National Taiwan University Hospital 32
Early research (Phase 1)Study completedNCT00418483
What this trial is testing

A Dose Escalation and Safety Study of Plasmin (Human) In Acute Lower Extremity Native Artery or Bypass Graft Occlusion

Who this might be right for
Arterial Occlusive Diseases
Grifols Therapeutics LLC 83
Not applicableStudy completedNCT02481011
What this trial is testing

Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs

Who this might be right for
Intracranial HemorrhagesStroke
St. Olavs Hospital 22,111
Testing effectiveness (Phase 2)WithdrawnNCT00541320
What this trial is testing

Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)

Who this might be right for
Venous Thromboembolism
GlaxoSmithKline
Not applicableStudy completedNCT01713491
What this trial is testing

Pre-stroke Cognitive Status and Thrombolytic Therapy

Who this might be right for
Brain IschemiaAdverse Effect of Thrombolytic DrugsImpaired Cognition+1 more
University Hospital, Lille 205
Not applicableStudy completedNCT03481257
What this trial is testing

Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel

Who this might be right for
Acute Coronary SyndromeAcute Myocardial InfarctionUnstable Angina
Seoul National University Hospital 56
Large-scale testing (Phase 3)UnknownNCT01346215
What this trial is testing

Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure

Who this might be right for
Chronic Renal Failure
Laboratório Químico Farmacêutico Bergamo Ltda. 132
Next Page